A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis
Chemotherapy typically destroys the tumor mass but rarely eradicates the cancer stem cells (CSCs) that can drive metastatic recurrence. A key current challenge is finding ways to eradicate CSCs and suppress their characteristics. Here, we report a prodrug, Nic-A, created by combining a carbonic anhy...
Sparad:
| Huvudupphovsmän: | , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | engelska |
| Publicerad: |
2023
|
| Länkar: | https://doi.org/10.1073/pnas.2304081120 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|